Unity Biotechnology, Inc.UBXNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank28
Year-over-Year Change
Year-over-year operating cash flow growth rate
Latest
-7.65%
↓ 49% vs avg
Percentile
P28
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
-5.15%
Historical baseline
| Period | Value |
|---|---|
| Q1 2025 | -7.65% |
| Q4 2024 | -13.71% |
| Q3 2024 | -13.29% |
| Q2 2024 | 11.56% |
| Q1 2024 | 31.58% |
| Q4 2023 | -6.48% |
| Q3 2023 | 35.81% |
| Q2 2023 | 2.06% |
| Q1 2023 | -9.16% |
| Q4 2022 | 4.51% |
| Q3 2022 | 26.82% |
| Q2 2022 | 0.92% |
| Q1 2022 | -197.71% |
| Q4 2021 | 56.48% |
| Q3 2021 | 13.66% |
| Q2 2021 | 11.31% |
| Q1 2021 | 9.71% |
| Q4 2020 | 3.17% |
| Q3 2020 | 10.49% |
| Q2 2020 | 23.09% |
| Q1 2020 | -59.79% |
| Q4 2019 | 6.78% |
| Q3 2019 | 12.79% |
| Q2 2019 | 6.29% |
| Q1 2019 | -60.83% |
| Q4 2018 | 7.77% |
| Q3 2018 | 23.07% |
| Q2 2018 | -51.89% |
| Q1 2018 | -2.44% |
| Q4 2017 | -27.18% |
| Q3 2017 | 6.71% |
| Q2 2017 | -24.39% |
| Q1 2017 | 0.00% |